` NVCN (Neovasc Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

NVCN
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, NVCN has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +21% growth.

Stocks Performance
NVCN vs S&P TSX Composite Index (Canada)

Loading
NVCN
S&P TSX Composite Index (Canada)
Add Stock

Performance Gap
NVCN vs S&P TSX Composite Index (Canada)

Loading
NVCN
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
NVCN vs S&P TSX Composite Index (Canada)

Loading
NVCN
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Neovasc Inc vs Peers

S&P TSX Composite Index (Canada)
NVCN
ABT
ISRG
BSX
SYK
Add Stock

Neovasc Inc
Glance View

Market Cap
110.5m CAD
Industry
Health Care

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

NVCN Intrinsic Value
Not Available
Back to Top